Anti-CGRP monoclonal antibodies for the treatment of chronic migraine: an overview of available results and comparison with the currently used prophylactics

被引：0
|
作者：
Vandervorst, Fenne [1 ]
Van Deun, Laura [1 ]
De Keyser, Jacques [1 ]
Versijpt, Jan [1 ]
机构：
[1] Univ Hosp Brussels, Dept Neurol, Brussels, Belgium
来源：
JOURNAL OF HEADACHE AND PAIN | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
    Iannone, Luigi Francesco
    De Cesaris, Francesco
    Ferrari, Anita
    Benemei, Silvia
    Fattori, Davide
    Chiarugi, Alberto
    [J]. CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
  • [22] The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine
    Guerzoni, Simona
    Baraldi, Carlo
    Pani, Luca
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5687 - 5695
  • [23] The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine
    Simona Guerzoni
    Carlo Baraldi
    Luca Pani
    [J]. Neurological Sciences, 2022, 43 : 5687 - 5695
  • [24] Eptinezumab Anti-CGRP monoclonal antibody Treatment of migraine
    Lu, Lingyun
    Liu, Meijun
    Hu, Songshan
    Liu, Yao
    Yang, Dongdong
    Hong, Peiwei
    [J]. DRUGS OF THE FUTURE, 2017, 42 (10) : 609 - 615
  • [25] Ketogenic Diet in resistant chronic migraine with failure to anti-CGRP monoclonal antibodies (KETOMIGRAINE)
    Ahmad, L.
    Allena, M.
    Tassorelli, C.
    Sances, G.
    Vaghi, G.
    Guaschino, E.
    Ghiotto, N.
    De Icco, R.
    Rondanelli, M.
    Mansueto, F.
    Barrile, G.
    Nichetti, M.
    Znaboni, A.
    Demartini, C.
    Greco, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 148 - 148
  • [26] Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
    Luigi Francesco Iannone
    Davide Fattori
    Martina Marangoni
    Silvia Benemei
    Alberto Chiarugi
    Pierangelo Geppetti
    Francesco De Cesaris
    [J]. CNS Drugs, 2023, 37 : 189 - 202
  • [27] Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
    Iannone, Luigi Francesco
    Fattori, Davide
    Marangoni, Martina
    Benemei, Silvia
    Chiarugi, Alberto
    Geppetti, Pierangelo
    De Cesaris, Francesco
    [J]. CNS DRUGS, 2023, 37 (02) : 189 - 202
  • [28] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [29] DO MULTIPLE TREATMENT CYCLES WITH ANTI-CGRP MONOCLONAL ANTIBODIES MODIFY MIGRAINE COURSE?
    Aurilia, C.
    Egeo, G.
    Proietti, S.
    Torelli, P.
    Cevoli, S.
    D'Onofrio, F.
    Bonassi, S.
    Barbanti, P.
    [J]. HEADACHE, 2023, 63 : 126 - 126
  • [30] Anti-CGRP Monoclonal Antibodies for the Treatment of Migraine with Aura: a prospective observational cohort study
    Braca, S.
    Russo, C.
    Miele, A.
    Stornaiuolo, A.
    Sansone, M.
    De Simone, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 376 - 376
12345